Nancy Valente is on the board of Myovant Sciences Ltd. and Immatics NV.

In the past Dr. Valente was Vice President-Clinical Development at Anosys, Inc., Vice President-Global Hematology Development at Genentech, Inc. and SVP & Lead-Global Product Development at Roche Pharmaceuticals, Inc.

She received an undergraduate degree and a doctorate from the University of Missouri.